Catheter Precision Corporation (VTAK) - מזומן למניה

Catheter Precision Corporation - לוגו גרפי של המנפיק VTAK

Surgeons' confidence in the VIVO arrhythmia detection system is driving capital inflows, as evidenced by the cash per share metric, where the latest value is recorded as 0.10. AI-driven VektorPlus automation optimizes operations, while consistent equipment sales to clinics ensure stable cash flows and predictable revenue growth for Catheter Precision (VTAK).

מזומנים למניה: Catheter Precision Corp (VTAK) עבור 21.02.2024 - 05.10.2026

פילוחי מדדים מקיפים ואנליטיקה עבור Catheter Precision Inc (VTAK)

- מדדי זמינות כספים ותזרימי מזומנים:
ניתוח מקיף של החברה:VTAK (Catheter Precision Corporation)
מוצר המיוצר על ידי Catheter Precision, Inc.

This indicator determines the share of liquid assets per common share. It measures the actual cash cushion available to cover liabilities or fund growth. By analyzing the cash per share metric, an investor identifies the balance between financial stability and capital efficiency. For Catheter Precision (VTAK), this is critical when scaling mapping systems in US clinics. A sufficient reserve ensures the expansion of the IT platform for surgeon training.